Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CDK2AP2P3 is a predicted human pseudogene based on its sequence similarity to CDK2AP2, a gene that encodes Cyclin-dependent kinase 2-associated protein 2. Unlike CDK2AP2, which is involved in cell cycle regulation and chromatin remodeling[2], CDK2AP2P3 does not encode a protein and is not considered a functional therapeutic target. Pseudogenes such as CDK2AP2P3 are usually non-functional remnants of genes and do not participate in protein-driven biological processes. Summary Context: - If your query is about a functional molecular target involved in cell cycle regulation, refer instead to CDK2AP2 (Cyclin-dependent kinase 2-associated protein 2)[2]. - The addition of “pseudogene” and the “3” suffix indicates this is a non-coding sequence and not relevant for therapeutic intervention or standard molecular biology research into protein targets. - No canonical functions, disease associations, interacting drugs, or known mechanisms are reported for this pseudogene.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclin-dependent kinase 2-associated protein 2 pseudogene 3 (CDK2AP2P3) (CDK2AP2P3).